These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 11860777)
1. [The serologic study on the blood transmission origin of HIV]. Zhu B; Wu N; Qiang L; Shao Y Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Apr; 21(2):140-2. PubMed ID: 11860777 [TBL] [Abstract][Full Text] [Related]
2. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
3. [Epidemiologic studies on HCV and HBV infections among intravenous drug users in the area with high HIV infection]. Cheng H Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Oct; 14(5):275-8. PubMed ID: 8137408 [TBL] [Abstract][Full Text] [Related]
4. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users]. Wang YC; Xu SH; Li XH; Song AJ; Jia XR; Zhuang H Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
7. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users. Devi KhS; Brajachand N; Singh HL; Singh YM J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404 [TBL] [Abstract][Full Text] [Related]
8. [Study on the epidemiology and distribution of human immunodeficiency virus-1 and hepatitis C virus infection among intravenous drug users and illegal blood donors in China]. Yin N; Mei S; Li L; Wei FL; Zhang LQ; Cao YZ Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):962-5. PubMed ID: 14687492 [TBL] [Abstract][Full Text] [Related]
9. Preliminary research on the co-infection of human immunodeficiency virus and hepatitis virus in intravenous drug users. Wu N; Li D; Zhu B; Zou W Chin Med J (Engl); 2003 Sep; 116(9):1318-20. PubMed ID: 14527356 [TBL] [Abstract][Full Text] [Related]
10. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales. Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors. Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285 [TBL] [Abstract][Full Text] [Related]
12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey. Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR; Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia. El-Hazmi MM Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374 [TBL] [Abstract][Full Text] [Related]
14. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028 [TBL] [Abstract][Full Text] [Related]
15. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856 [TBL] [Abstract][Full Text] [Related]
16. [HBV, HCV and HIV infections among drug addicts-residents of rehabilitation and social adjustment centers in the Gdańsk district]. Smiatacz T; Własiuk M; Paszkiewicz J; Zielińska W Przegl Epidemiol; 1991; 45(4):351-5. PubMed ID: 1841415 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of human immunodeficiency virus (HIV), hepatitis B virus, and hepatitis C virus in three groups of populations at high risk of HIV infection in Amritsar (Punjab), Northern India. Jindal N; Arora U; Singh K Jpn J Infect Dis; 2008 Jan; 61(1):79-81. PubMed ID: 18219142 [TBL] [Abstract][Full Text] [Related]
18. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice. Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233 [TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico]. Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281 [TBL] [Abstract][Full Text] [Related]
20. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users. Devi KhS; Singh NB; Singh HL; Singh YM J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]